# WAYRILZ

NDC: 58468-0251
Generic name: rilzabrutinib
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250829

FDA application: NDA219685

## Active ingredients

- RILZABRUTINIB: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0251"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0251
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0